Full-Time

Director – Discovery Chemistry

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Expert

Cambridge, MA, USA

70% in-office presence required.

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. in Chemistry and minimum 10 years of pharmaceutical/biotech industry with a demonstrable history of intellectual leadership in drug discovery, with a track record of patents, peer-reviewed publications, and project achievements
  • Ability to work independently, manage multiple projects concurrently, collaborate across disciplines and lead interdisciplinary activities to deliver project milestones.
  • Demonstrated strong synthetic chemistry expertise and proficiency in analytical techniques
  • Team-oriented, execution-focused, and highly motivated, with strong work ethic.
  • Experience in nucleotide and lipid chemistry is preferred.
Responsibilities
  • Provide strategic and technical leadership to drive the design and optimization of novel LNP components and synthetic mRNA components
  • Direct functions/teams, programs, and research strategy towards overall departmental goals
  • Lead medicinal chemistry efforts directed at the discovery of novel components of delivery vehicles for nucleic acid-based payloads
  • Solve complex scientific challenges within an emerging and increasingly competitive field of drug discovery
  • Manage, mentor, and coach a team of chemistry colleagues
  • Work within cross functional teams to evaluate and optimize the efficiency and safety of our delivery technologies
  • Design in vitro and in vivo experiments to evaluate novel designs; analyze, collate, and communicate data to the team and to senior leadership
  • Collaborate with internal stakeholders, including project management, intellectual property, and regulatory teams, to achieve project goals
  • Effectively communicate scientific findings, progress updates, and project strategies to senior management and external stakeholders
  • Contribute to CMC aspects as it relates to novel lipids

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?